Skip to main content
. 2020 Jun 24;9(6):550. doi: 10.3390/antiox9060550

Figure 4.

Figure 4

Impact of E3330 on the viability of H1975 cells treated with cisplatin. Cells were pre-incubated with E3330 (30 µM) for 3 h and then simultaneously exposed to E3330 and cisplatin (5–20 µM) for 72 h. The effects in terms of cell viability were evaluated using the CV staining assay (A) and MTS reduction assay (B). Values represent mean ± SD (n = 3–5) and are expressed as percentages relative to vehicle-treated control cells. * p < 0.05 and ** p < 0.01 relative to respective cisplatin-treated cells (Student’s t-test).